THRIVE 2.0 Program for Preventing Childhood Obesity
(THRIVE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to test a responsive parenting obesity prevention program with infants and caregivers of color (e.g., non-White; Hispanic/Latinx) and/or who are economically marginalized (i.e., publicly insured), delivered via Integrated Behavioral Health (IBH) in pediatric primary care. The main questions it aims to answer are:* 1) Is the obesity prevention intervention delivered via IBH in pediatric primary care feasible and acceptable to families of color and/or families who are economically marginalized?* 2) Will it prevent rapid weight gain during infancy?Participants will complete baseline (newborn), post-treatment (9 months), and follow-up assessments (12 months). Participants assigned to treatment will receive 4 prevention sessions as part of their typical well-child visit in pediatric primary care. Researchers hypothesize that infants in the obesity prevention intervention will have stable weight gain compared to infants in the control group (treatment as usual) will experience more rapid weight gain.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether participants need to stop taking their current medications.
Is the THRIVE 2.0 program safe for preventing childhood obesity?
How is the THRIVE 2.0 treatment different from other treatments for preventing childhood obesity?
THRIVE 2.0 is unique because it focuses on teaching parents responsive parenting techniques during infancy to promote healthy growth and self-regulation, which can help prevent obesity. Unlike other treatments that might focus on diet or exercise alone, this approach emphasizes the parent-child relationship and feeding practices to reduce the risk of overeating and overweight.13678
What data supports the effectiveness of the THRIVE 2.0 treatment for preventing childhood obesity?
Research shows that responsive parenting interventions, like THRIVE 2.0, can help prevent childhood obesity by promoting healthy growth and self-regulation in infants. Studies have found that such interventions improve parent-child relationships and reduce the risk of overweight/obesity without focusing directly on diet or exercise.123910
Who Is on the Research Team?
Tiffany Rybak, PhD
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Are You a Good Fit for This Trial?
This trial is for infants of color or from low-income families, born weighing at least 2500 grams and delivered between 37-42 weeks. They must be receiving care in the study's pediatric primary care setting and have English-speaking caregivers. Infants with certain health conditions, drug exposures, or whose families plan to move away within a year are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the THRIVE 2.0 responsive parenting intervention during well-child visits at 1, 2, 4, and 6 months
Post-treatment Assessment
Assessment of primary and secondary outcomes, including conditional weight gain and various questionnaires
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 12 months
What Are the Treatments Tested in This Trial?
Interventions
- THRIVE 2.0
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital Medical Center, Cincinnati
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator